Delivery Order SPE2DB22D2108-SPE2DB24FU3YY
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the medication Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $1,100.32. The award is a firm fixed price contract with a period of performance ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (2.5 mg/0.5 ml pen 0.5 ml). The fixed-price contract has a ceiling value of $1,360.45 and a completion date of May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Mounjaro 5 mg/0.5 ml pen. The order has a ceiling value of $2,941.50 and a completion date of March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $21,606.55 and has an ultimate completion date of January 17, 2025. It is for the procurement of the drug Mounjaro, a 12.5 mg/0.5 mL pen with a 0.5 mL volume. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract has a ceiling value of $4,114.07 and an ultimate completion date of May 13, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $2,630.00 order is for the drug Mounjaro 5 mg/0.5 ml pen, with a completion date of February 2, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the prime contractor, which serves as the primary...
- This is a $6,283.30 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The order is for the drug Mounjaro, a 7.5 mg/0.5 ml pen, with a period of performance through April 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp. for the medication Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml). The award has a ceiling value of $1,668.36 and a total completion date of August 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a variety of critical medical...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,838.96 firm fixed-price contract is for the supply of Mounjaro, a 12.5 mg/0.5 ml medication pen, with a completion date of April 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,071.30, is for the procurement of the drug Mounjaro, a 5 mg/0.5 ml medication pen. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU3YYDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $5,329.32. The contract is a firm fixed-price delivery order with a completion date of May 13, 2024. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., has an extensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not utilize any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 5/10/24 |